JP6898856B2 - 長時間作用型薬物送達装置および避妊におけるその使用 - Google Patents

長時間作用型薬物送達装置および避妊におけるその使用 Download PDF

Info

Publication number
JP6898856B2
JP6898856B2 JP2017558678A JP2017558678A JP6898856B2 JP 6898856 B2 JP6898856 B2 JP 6898856B2 JP 2017558678 A JP2017558678 A JP 2017558678A JP 2017558678 A JP2017558678 A JP 2017558678A JP 6898856 B2 JP6898856 B2 JP 6898856B2
Authority
JP
Japan
Prior art keywords
drug
core
lng
release
membrane
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2017558678A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018516889A (ja
JP2018516889A5 (enExample
Inventor
ホルムバリ，スヴァンテ
タールリング，クリスティーネ
Original Assignee
バイエル・オーイュー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by バイエル・オーイュー filed Critical バイエル・オーイュー
Publication of JP2018516889A publication Critical patent/JP2018516889A/ja
Publication of JP2018516889A5 publication Critical patent/JP2018516889A5/ja
Application granted granted Critical
Publication of JP6898856B2 publication Critical patent/JP6898856B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0039—Devices retained in the uterus for a prolonged period, e.g. intrauterine devices for contraception
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
JP2017558678A 2015-05-13 2016-05-09 長時間作用型薬物送達装置および避妊におけるその使用 Active JP6898856B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP15167521.2 2015-05-13
EP15167521 2015-05-13
PCT/EP2016/060298 WO2016180764A1 (en) 2015-05-13 2016-05-09 A long acting drug delivery device and its use in contraception

Publications (3)

Publication Number Publication Date
JP2018516889A JP2018516889A (ja) 2018-06-28
JP2018516889A5 JP2018516889A5 (enExample) 2020-07-02
JP6898856B2 true JP6898856B2 (ja) 2021-07-07

Family

ID=53174913

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017558678A Active JP6898856B2 (ja) 2015-05-13 2016-05-09 長時間作用型薬物送達装置および避妊におけるその使用

Country Status (8)

Country Link
US (2) US11096888B2 (enExample)
EP (1) EP3294300B1 (enExample)
JP (1) JP6898856B2 (enExample)
CN (1) CN108135910B (enExample)
CA (1) CA2985717A1 (enExample)
ES (1) ES3009909T3 (enExample)
FI (1) FI3294300T3 (enExample)
WO (1) WO2016180764A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2018340266A1 (en) * 2017-09-27 2020-03-05 Bayer Oy A method for modifying release of a therapeutically active agent from an elastomeric matrix
WO2019222856A1 (en) 2018-05-24 2019-11-28 Nureva Inc. Method, apparatus and computer-readable media to manage semi-constant (persistent) sound sources in microphone pickup/focus zones
WO2019226519A1 (en) 2018-05-24 2019-11-28 Celanese EVA Performance Polymers Corporation Implantable device for sustained release of a macromolecular drug compound
EP3801462A4 (en) 2018-05-24 2022-03-16 Celanese EVA Performance Polymers LLC Implantable device for sustained release of a macromolecular drug compound
US20230404911A1 (en) * 2018-12-11 2023-12-21 Lupin Inc. Drug delivery system for ultra-low dose estrogen combinations and methods and uses thereof
CA3122847A1 (en) * 2018-12-11 2020-06-18 Lupin Inc. Drug delivery system for ultra-low dose estrogen combinations and methods and uses thereof
CN112315898B (zh) * 2020-11-04 2021-08-13 国家卫生健康委科学技术研究所 含有芳香化酶抑制剂的阴道缓控释给药系统及其制备方法
JP2024515220A (ja) 2021-04-26 2024-04-05 セラニーズ・イーブイエイ・パフォーマンス・ポリマーズ・エルエルシー 高分子薬剤化合物の持続放出用の埋め込み型デバイス

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3920805A (en) 1971-12-09 1975-11-18 Upjohn Co Pharmaceutical devices and method
US4215691A (en) 1978-10-11 1980-08-05 Alza Corporation Vaginal contraceptive system made from block copolymer
US4292965A (en) 1978-12-29 1981-10-06 The Population Council, Inc. Intravaginal ring
DE3040978A1 (de) 1980-10-28 1982-05-27 Schering Ag, 1000 Berlin Und 4619 Bergkamen Vaginalring
FR2618329B1 (fr) 1987-07-22 1997-03-28 Dow Corning Sa Procede de fabrication d'un anneau capable d'assurer la liberation d'un agent therapeutique, et anneau fabrique par ce procede
FI90627C (fi) 1992-07-31 1994-03-10 Leiras Oy Laitteisto lääkeainesauvan varustamiseksi vaipalla
PH30867A (en) 1992-07-31 1997-12-09 Leiras Oy Method and equipment for installing a medicine capsule on a support.
EP0836473B1 (en) * 1995-07-04 2001-10-31 Akzo Nobel N.V. Ring-shaped devices
IL123813A0 (en) * 1997-04-11 1998-10-30 Akzo Nobel Nv Drug delivery system for two or more active substances
FI107339B (fi) 1998-06-30 2001-07-13 Leiras Oy Lääkeaineiden läpäisynopeutta säätävä kalvo tai matriisi
US6056976A (en) 1998-11-12 2000-05-02 Leiras Oy Elastomer, its preparation and use
US6063395A (en) * 1998-11-12 2000-05-16 Leiras Oy Drug delivery device especially for the delivery of progestins and estrogens
US6476079B1 (en) * 1999-12-23 2002-11-05 Leiras Oy Devices for the delivery of drugs having antiprogestinic properties
AU2002313517B2 (en) 2001-08-31 2007-09-06 Bayer Schering Pharma Oy Drug delivery system
ATE461681T1 (de) * 2003-04-29 2010-04-15 Gen Hospital Corp Verfahren und vorrichtungen für die verzögerte freisetzung von mehreren arzneimitteln
TW200927141A (en) * 2007-11-22 2009-07-01 Bayer Schering Pharma Oy Vaginal delivery system
EP2062568A1 (en) * 2007-11-22 2009-05-27 Bayer Schering Pharma Oy Vaginal delivery system
EP2140860A1 (en) 2008-07-03 2010-01-06 Bayer Schering Pharma Oy An improved method of contraception
FI121000B (fi) 2008-11-19 2010-06-15 Bayer Schering Pharma Oy Intravaginaalinen antojärjestelmä ja menetelmä sen valmistamiseksi
MX357598B (es) * 2011-07-20 2018-07-16 F Kiser Patrick Dispositivos intravaginales para administración de fármaco.
WO2014122563A1 (en) * 2013-02-08 2014-08-14 Qpharma Ab An intra vaginal device, and a method of reducing the rate of diffusion of active ingredients in said intra vaginal device

Also Published As

Publication number Publication date
EP3294300B1 (en) 2024-12-18
ES3009909T3 (en) 2025-03-31
US20180104181A1 (en) 2018-04-19
JP2018516889A (ja) 2018-06-28
CN108135910B (zh) 2022-12-02
US20210338573A1 (en) 2021-11-04
FI3294300T3 (fi) 2025-03-06
CN108135910A (zh) 2018-06-08
US11096888B2 (en) 2021-08-24
US12357563B2 (en) 2025-07-15
WO2016180764A1 (en) 2016-11-17
EP3294300A1 (en) 2018-03-21
CA2985717A1 (en) 2016-11-17

Similar Documents

Publication Publication Date Title
JP6898856B2 (ja) 長時間作用型薬物送達装置および避妊におけるその使用
US10532025B2 (en) Intrauterine delivery system for contraception
Malcolm et al. Vaginal rings for delivery of HIV microbicides
RU2607179C2 (ru) Интравагинальные устройства для доставки лекарственных средсв
DK2419108T3 (en) A method for on-demand control of conception,
JP2010539205A (ja) ドラッグデリバリーシステム
TW201201799A (en) Parenteral dosage form releasing aromatase inhibitors and progestins to treat endometriosis
SK5132001A3 (en) Drug delivery device, especially for the delivery of progestins and estrogens
JP2008543935A (ja) 避妊用の制御された薬物送達器具のための新たな投薬計画
US11400059B2 (en) Treatment of pain and/or pain related symptoms associated with dysmenorrhea
JP2016539088A (ja) 子宮内送達システム
Teller et al. Intravaginal flux controlled pump for sustained release of macromolecules
AU2020282388A1 (en) Methods, compositions and devices for treating neuroinflammatory conditions
Fetherston et al. Controlled-release vaginal ring drug-delivery systems: a key strategy for the development of effective HIV microbicides
WO2018202574A1 (en) Intravaginal drug delivery system, method for manufacturing such system and its use in gynecological therapies and contraception
US20170312219A1 (en) Method of contraception
EP2799043B1 (en) Vaginal ring including meloxicam and an agent for modulating the release of the active principle, which can be used as a continuous-use contraceptive in women
Zydowsky Development of User-initiated Vaginal Dosage Forms
Young A modular device for vaginal administration of multiple therapeutic agents
Malcolm Vaginal rings for controlled-release drug delivery
Tong ASSESSMENT OF THE PROGESTIN POLYMERIC VAGINAL FILMS BY AN OPTIMIZED SOLVENT-CAST PLATFORM

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20190204

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20191126

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20200220

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20200525

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20201006

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20201228

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210405

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20210608

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20210611

R150 Certificate of patent or registration of utility model

Ref document number: 6898856

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250